These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 35275749
21. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. Simon A, Amaro MI, Cabral LM, Healy AM, de Sousa VP. Int J Pharm; 2016 Mar 30; 501(1-2):124-38. PubMed ID: 26836711 [Abstract] [Full Text] [Related]
22. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation. Li L, Leung SSY, Gengenbach T, Yu J, Gao GF, Tang P, Zhou QT, Chan HK. Int J Pharm; 2017 Sep 15; 530(1-2):30-39. PubMed ID: 28709940 [Abstract] [Full Text] [Related]
23. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery. Li X, Mansour HM. AAPS PharmSciTech; 2011 Dec 15; 12(4):1420-30. PubMed ID: 22038473 [Abstract] [Full Text] [Related]
24. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis. Momin MAM, Sinha S, Tucker IG, Doyle C, Das SC. Int J Pharm; 2017 Aug 07; 528(1-2):107-117. PubMed ID: 28583333 [Abstract] [Full Text] [Related]
25. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery. Wu X, Zhang W, Hayes D, Mansour HM. Int J Nanomedicine; 2013 Aug 07; 8():1269-83. PubMed ID: 23569375 [Abstract] [Full Text] [Related]
26. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders. Yu J, Romeo MC, Cavallaro AA, Chan HK. Int J Pharm; 2018 Apr 25; 541(1-2):11-18. PubMed ID: 29454904 [Abstract] [Full Text] [Related]
27. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation. Zhou QT, Morton DA, Yu HH, Jacob J, Wang J, Li J, Chan HK. J Pharm Sci; 2013 Oct 25; 102(10):3736-47. PubMed ID: 23904207 [Abstract] [Full Text] [Related]
28. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy. Acosta MF, Muralidharan P, Grijalva CL, Abrahamson MD, Hayes D, Fineman JR, Black SM, Mansour HM. Ther Adv Respir Dis; 2021 Oct 25; 15():1753466621998245. PubMed ID: 33719747 [No Abstract] [Full Text] [Related]
29. Co-spray dried inhalable composite powders of ciprofloxacin and alginate oligosaccharide as anti-biofilm therapy. Zhang L, Bera H, Guo Y, Shi C, Ulrik Lind J, Radeke C, Wang J, Wang H, Zhao X, Cun D, Yang M. Int J Pharm; 2024 Apr 10; 654():123949. PubMed ID: 38417723 [Abstract] [Full Text] [Related]
30. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. Meenach SA, Anderson KW, Zach Hilt J, McGarry RC, Mansour HM. Eur J Pharm Sci; 2013 Jul 16; 49(4):699-711. PubMed ID: 23707466 [Abstract] [Full Text] [Related]
31. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection. Arora S, Haghi M, Loo CY, Traini D, Young PM, Jain S. Mol Pharm; 2015 Jun 01; 12(6):2001-9. PubMed ID: 25923171 [Abstract] [Full Text] [Related]
32. Remdesivir powders manufactured by jet milling for potential pulmonary treatment of COVID-19. Ruan X, Yu J, Miao H, Li R, Tong Z. Pharm Dev Technol; 2022 Jul 01; 27(6):635-645. PubMed ID: 35787731 [Abstract] [Full Text] [Related]
33. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery. Li X, Vogt FG, Hayes D, Mansour HM. Eur J Pharm Sci; 2014 Feb 14; 52():191-205. PubMed ID: 24215736 [Abstract] [Full Text] [Related]
34. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery. Gomez AI, Acosta MF, Muralidharan P, Yuan JX, Black SM, Hayes D, Mansour HM. Pulm Pharmacol Ther; 2020 Oct 14; 64():101975. PubMed ID: 33137515 [Abstract] [Full Text] [Related]
35. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin. Momin MAM, Tucker IG, Das SC. Drug Dev Ind Pharm; 2019 Jul 14; 45(7):1205-1213. PubMed ID: 30990097 [Abstract] [Full Text] [Related]
36. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin. Pathak V, Park H, Zemlyanov D, Bhujbal SV, Ahmed MU, Azad MAK, Li J, Zhou QT. Pharm Res; 2022 Nov 14; 39(11):2781-2799. PubMed ID: 35915320 [Abstract] [Full Text] [Related]
37. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations. Liu T, Tong S, Liao Q, Pan L, Cheng M, Rantanen J, Cun D, Yang M. Int J Pharm; 2023 Mar 25; 635():122702. PubMed ID: 36773729 [Abstract] [Full Text] [Related]
38. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles. Marasini N, Sheikh Z, Wong CYJ, Hosseini M, Spicer PT, Young P, Xin Ong H, Traini D. Int J Pharm; 2022 Aug 25; 624():121989. PubMed ID: 35809834 [Abstract] [Full Text] [Related]
39. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation. Wu X, Hayes D, Zwischenberger JB, Kuhn RJ, Mansour HM. Drug Des Devel Ther; 2013 Aug 25; 7():59-72. PubMed ID: 23403805 [Abstract] [Full Text] [Related]
40. Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration. Seow HC, Liao Q, Lau ATY, Leung SWS, Yuan S, Lam JKW. Int J Pharm; 2022 May 10; 619():121704. PubMed ID: 35358643 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]